研究者学術情報データベース

イチムラ　アツヒコ
市村　敦彦
ICHIMURA ATSUHIKO

所属薬学部薬学科

職名准教授

論文
1.	2023/12/20	Atypical cell death and insufficient matrix organization in long-bone growth plates from Tric-b-knockout mice │ Cell Death & Disease │ 14 (12) (共著)
2.	2022/03/15	C-type natriuretic peptide facilitates autonomic Ca2+ entry in growth plate chondrocytes for stimulating bone growth │ eLife │ 11 (共著)
3.	2022/03	C型ナトリウムペプチドによる軟骨細胞内Ca2+活性化と骨伸長作用の解析 │ 日本応用酵素協会誌 │ (56),68-68頁 (単著)
4.	2022/03	分子から迫る神経薬理学 FFAR(free fatty acid receptor、遊離脂肪酸受容体)の臨床応用 │ Clinical Neuroscience │ 40 (3),284-287頁 (単著)
5.	2022/02	分子から迫る神経薬理学 FFAR(free fatty acid receptor、遊離脂肪酸受容体)の生理的および薬理的作用 │ Clinical Neuroscience │ 40 (2),143-145頁 (単著)
6.	2022/01	分子から迫る神経薬理学 FFAR(free fatty acid receptor、遊離脂肪酸受容体)の種類 │ Clinical Neuroscience │ 40 (1),11-14頁 (単著)
7.	2022	Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120. │ Frontiers in immunology │ 13,929690-929690頁 (共著)
8.	2021/06	Enhanced Ca²⁺ handling in thioglycolate-elicited peritoneal macrophages │ Cell Calcium │ 96,102381-102381頁 (共著)
9.	2021/03	軟骨細胞における細胞内Ca2+制御機構と生理機能の解析 │ 日本応用酵素協会誌 │ (55),49-50頁 (単著)
10.	2020/11/16	Total Synthesis of Zephycarinatines via Photocatalytic Reductive Radical ipso-Cyclization │ Angewandte Chemie - International Edition │ 59 (47),21210-21215頁 (共著)
11.	2020/01	Free fatty acid receptors in health and disease │ Physiological Reviews │ 100 (1),171-210頁 (共著)
12.	2019/12/01	Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids │ Nature Communications │ 10 (1),4007-4007頁 (共著)
13.	2019/04/09	TRPM7 channels mediate spontaneous Ca2+ fluctuations in growth plate chondrocytes that promote bone development. │ Science signaling │ 12 (576) (共著)
14.	2019/03	軟骨細胞におけるCa2+動態の分子機構及び生理機能の解明 │ 日本応用酵素協会誌 │ (53),59-60頁 (単著)
15.	2019	Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation. │ Frontiers in endocrinology │ 10,157-157頁 (共著)
16.	2018/06	Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance. │ Nature neuroscience │ 21 (6),820-833頁 (共著)
17.	2018/04/11	Furan- and Thiophene-2-Carbonyl Amino Acid Derivatives Activate Hypoxia-Inducible Factor via Inhibition of Factor Inhibiting Hypoxia-Inducible Factor-1. │ Molecules (Basel, Switzerland) │ 23 (4) (共著)
18.	2018/03	小胞体カウンターイオンチャネルTRIC-Bの骨形成不全症における病態生理学的解析 │ 日本応用酵素協会誌 │ (52),61-61頁 (単著)
19.	2018/02/05	The natural flavonoid myricetin inhibits gastric H+, K+-ATPase. │ European journal of pharmacology │ 820,217-221頁 (共著)
20.	2018/02	Gm7325 Transcription Is Regulated by MyoD in Activated Muscle Satellite Cells │ Biophysical Journal │ 114 (3),628a (共著)
21.	2017/08	新規PAI-1阻害剤はマウス骨髄除去モデルにおいて骨形成を促進する │ 日本整形外科学会雑誌 │ 91 (8),S1568-S1568頁 (共著)
22.	2017/08	新規PAI-1阻害薬は閉経後骨粗鬆症モデルの骨密度を回復させる │ 日本整形外科学会雑誌 │ 91 (8),S1711-S1711頁 (共著)
23.	2017/06	Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice. │ FASEB journal : official publication of the Federation of American Societies for Experimental Biology │ 31 (6),2625-2637頁 (共著)
24.	2017/03	小胞体カウンターイオンチャネルTRIC-Bの骨形成不全症における病態生理学的解析 │ 日本応用酵素協会誌 │ (51),65-66頁 (単著)
25.	2017/02	病理学 TRIC-B遺伝子変異による骨形成不全症 │ 医学のあゆみ │ 260 (7),605-606頁 (共著)
26.	2017/01	生物系薬学 Pitx2は抗酸化応答の活性化によって傷害後の心臓修復を促進する │ ファルマシア │ 53 (1),64-64頁 (単著)
27.	2017	Gm7325 is MyoD-dependently expressed in activated muscle satellite cells. │ Biomedical research (Tokyo, Japan) │ 38 (3),215-219頁 (共著)
28.	2017	Polymorphic Variation in FFA Receptors: Functions and Consequences. │ Handbook of experimental pharmacology │ 236,133-158頁 (単著)
29.	2016/05/17	Mice lacking the intracellular cation channel TRIC-B have compromised collagen production and impaired bone mineralization. │ Science signaling │ 9 (428),ra49 (共著)
30.	2016/04	Physiological function of short-chain fatty acid receptor under ketogenic condition │ FASEB JOURNAL │ 30 (共著)
31.	2016/03/25	Nutritional Signaling via Free Fatty Acid Receptors. │ International journal of molecular sciences │ 17 (4),450-450頁 (共著)
32.	2016	TRIC-B Mutations Causing Osteogenesis Imperfecta. │ Biological & pharmaceutical bulletin │ 39 (11),1743-1747頁 (共著)
33.	2015/04/28	Mitsugumin 56 (hedgehog acyltransferase-like) is a sarcoplasmic reticulum-resident protein essential for postnatal muscle maturation. │ FEBS letters │ 589 (10),1095-104頁 (共著)
34.	2015/04/14	Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. │ Nutrients │ 7 (4),2839-49頁 (共著)
35.	2015	A novel antidiabetic therapy: free fatty acid receptors as potential drug target. │ Current diabetes reviews │ 11 (2),107-15頁 (共著)
36.	2015	Editorial: Obesity and Diabetes: Energy Regulation by Free Fatty Acid Receptors. │ Frontiers in endocrinology │ 6 (NOV),178-178頁 (共著)
37.	2015	Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer. │ Cancer biology & therapy │ 16 (2),253-60頁 (共著)
38.	2015	Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis. │ PloS one │ 10 (4),e0124510 (共著)
39.	2015	Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity. │ PloS one │ 10 (7),e0133786 (共著)
40.	2014/09	Role of free fatty acid receptors in the regulation of energy metabolism. │ Biochimica et biophysica acta │ 1841 (9),1292-300頁 (共著)
41.	2014/04	Plasminogen activator inhibitor-1(PAI-1)分子新たな生理的役割と臨床応用 │ 臨床血液 │ 55 (4),396-404頁 (共著)
42.	2014	Free fatty acid receptors as therapeutic targets for the treatment of diabetes. │ Frontiers in pharmacology │ 5 (NOV),236-236頁 (共著)
43.	2014	Regulation of Energy Homeostasis via GPR120. │ Frontiers in endocrinology │ 5 (JUL),111-111頁 (共著)
44.	2014	Therapeutic role and ligands of medium- to long-chain Fatty Acid receptors. │ Frontiers in endocrinology │ 5 (JUN),83-83頁 (共著)
45.	2014	乳糖不耐と遊離脂肪酸をリガンドとするGPCR(G-protein coupled receptor) │ 乳業技術 │ 64,1-9頁 (共著)
46.	2013/11/19	Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence. │ Circulation │ 128 (21),2318-24頁 (共著)
47.	2013/08	PAI-1阻害薬の臨床応用 │ 日本血栓止血学会誌 │ 24 (4),387-391頁 (共著)
48.	2013/08	【CKDと血栓】CKDと抗血栓療法 CKDにおける抗血栓療法の新たな展開 │ 血栓と循環 │ 21 (2),137-143頁 (共著)
49.	2013/05	A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration. │ Arteriosclerosis, thrombosis, and vascular biology │ 33 (5),935-42頁 (共著)
50.	2013/02	【肥満症-肥満症の最新知見-】食事性肥満とGPR120遺伝子 │ 日本臨床 │ 71 (2),350-354頁 (共著)
51.	2013/02	特論食事性肥満とGPR120遺伝子 (特集肥満症 : 肥満症の最新知見) │ 日本臨床 │ 71 (2),350-354頁 (単著)
52.	2013	Free fatty acid receptors and their role in regulation of energy metabolism. │ Reviews of physiology, biochemistry and pharmacology │ 164,77-116頁 (共著)
53.	2012/12/01	脂肪酸受容体の生理機能と創薬標的としての可能性 │ 日本薬理學雜誌 = Folia pharmacologica Japonica │ 140 (6),275-279頁 (共著)
54.	2012/12	[Physiological functions of fatty acid receptors and their therapeutic potential]. │ Nihon yakurigaku zasshi. Folia pharmacologica Japonica │ 140 (6),275-9頁 (共著)
55.	2012/05	Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. │ American journal of hypertension │ 25 (5),604-11頁 (共著)
56.	2012/05	【CKDと脳心血管疾患との密接な関連を読み解く】脳心腎連関における危険因子の関与血管老化の関与 AGEを中心に │ Circulation │ 2 (5),51-58頁 (共著)
57.	2012/04	糸球体障害におけるポドサイトの役割と新規Plasminogen activator inhibitor(PAI)-1阻害薬TM5275の効果 │ 日本腎臓学会誌 │ 54 (3),226-226頁 (共著)
58.	2012/03	The alteration of insaturated fatty acid receptors of type-omega-3 GPR120 leads to obesity in Men and Mice │ DIABETES & METABOLISM │ 38,A13-A13頁 (共著)
59.	2012/02/19	Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. │ Nature │ 483 (7389),350-4頁 (共著)
60.	2011/12/31	創薬標的としての遊離脂肪酸受容体 : 循環器疾患とメタボリックシンドローム │ 血管 │ 34 (4),145-152頁 (共著)
61.	2011/09	Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. │ Journal of pharmaceutical sciences │ 100 (9),3594-601頁 (共著)
62.	2011/05/10	Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). │ Proceedings of the National Academy of Sciences of the United States of America │ 108 (19),8030-5頁 (共著)
63.	2011/05	miRNAs and regulation of cell signaling. │ The FEBS journal │ 278 (10),1610-8頁 (共著)
64.	2011/01	脂肪酸受容体GPR120機能不全は食餌誘発性の肥満及び脂肪肝を惹起する │ 血管 │ 34 (1),36-36頁 (共著)
65.	2011	[Free fatty acid receptors and their physiological role in metabolic regulation]. │ Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan │ 131 (12),1683-9頁 (共著)
66.	2011	消化管脂肪酸受容体とその生理作用 │ 薬学雑誌. 乙号 │ 131 (12),1683-1689頁 (共著)
67.	2010/10/28	脂肪酸受容体 : メタボリックシンドロームと循環器系疾患 │ 血管 │ 33 (3),81-87頁 (共著)
68.	2010/06	MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. │ Molecular pharmacology │ 77 (6),1016-24頁 (共著)
69.	2010/03	Novel function of long-chain free fatty acid receptor GPR120 │ ENDOCRINE JOURNAL │ 57,S231-S231頁 (共著)
70.	2010/01	短鎖脂肪酸受容体の交感神経を介した循環器系機能へ及ぼす影響 │ 血管 │ 33 (1),35-35頁 (共著)
71.	2010	New frontiers in gut nutrient sensor research: free fatty acid sensing in the gastrointestinal tract. │ Journal of pharmacological sciences │ 112 (1),19-24頁 (共著)
72.	2010	Role of free fatty acid receptor GPR120 in metabolic regulation │ JOURNAL OF PHARMACOLOGICAL SCIENCES │ 112,20P-20P頁 (共著)
73.	2009/09	Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. │ Prostaglandins & other lipid mediators │ 89 (3-4),82-8頁 (共著)
74.	2009/06	Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. │ The FEBS journal │ 276 (12),3269-76頁 (共著)
75.	2009	Fat sensing in the gut │ JOURNAL OF PHARMACOLOGICAL SCIENCES │ 109,46P-46P頁 (共著)
76.	2008/04	In silico approach to identify the expression of the undiscovered molecules from microarray public database: identification of odorant receptors expressed in non-olfactory tissues. │ Naunyn-Schmiedeberg's archives of pharmacology │ 377 (2),159-65頁 (共著)
77.	2008	Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. │ Journal of human genetics │ 53 (6),515-515頁 (共著)